Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > warrants Aug 22

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Aug 19, 2024 5:32pm

179 Views

Post# 36186768

RE:RE:RE:RE:RE:RE:warrants Aug 22

Having the warrants excercised would be more beneficial, as it would bring in 20$ Million in cash at 35 cents and not 22 or 18 cents a share. But if they don't get excercised then $5 million from one big investor would definitely also be welcome. Cash from whatever source will allow the company to proceed on multiple fronts.

<< Previous

Bullboard Posts

Next >>

Mullen Group's Robust Case for Value, Part 1: Less-than-Truckload